MedPath

PHARMENG TECHNOLOGY PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

HSA:7

Drug Approvals

URSOSAN HARD CAPSULES 250 MG

Approval Date
Jan 5, 2024
HSA

URSOSAN FORTE FILM-COATED TABLETS 500MG

Approval Date
Dec 19, 2023
HSA

NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED)

Approval Date
Oct 17, 2023
HSA

FESPIXON CREAM

Approval Date
Jan 31, 2023
HSA

PLIAGLIS CREAM 70mg/g + 70mg/g

Approval Date
Jun 2, 2015
HSA

TACHOSIL, MEDICATED SPONGE

Approval Date
Nov 20, 2013
HSA

Pandemic Influenza Vaccine H5N1 Baxter Suspension for Injection

Approval Date
Dec 19, 2012
HSA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.